Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13877 | 743 | 25.6 | 56% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1479 | 7136 | GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LYMPHOCYTE IMMUNOSUPPRESSANT SENSITIVITY TEST LIST | Author keyword | 6 | 100% | 1% | 4 |
| 2 | LYMPHOCYTE SENSITIVITY | Author keyword | 3 | 60% | 0% | 3 |
| 3 | T CELL MITOGEN | Author keyword | 2 | 38% | 1% | 5 |
| 4 | MOTOYAMAKITA MACHI HIGASHINADA KU | Address | 2 | 67% | 0% | 2 |
| 5 | 3 4 5 DIMETHYLTHIAZOL 2 YL 2 5 DIPHENYL TETRAZOLIUM BROMIDE MTT | Author keyword | 2 | 50% | 0% | 3 |
| 6 | CLIN NEPHROL RHEUMATOL P MED INFECT CONT | Address | 1 | 38% | 0% | 3 |
| 7 | ATTENUATION OF APOPTOSIS | Author keyword | 1 | 100% | 0% | 2 |
| 8 | LYMPHOCYTE IMMUNOSUPPRESSANT SENSITIVITY TEST | Author keyword | 1 | 100% | 0% | 2 |
| 9 | OXIDIZED GLUCOCORTICOID | Author keyword | 1 | 100% | 0% | 2 |
| 10 | PHARM 565 HOCHSTETTER HALL | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TYROSINE AMINOTRANSFERASE INDUCTION | 30 | 79% | 3% | 19 |
| 2 | CORTICOSTEROID PHARMACODYNAMICS | 21 | 90% | 1% | 9 |
| 3 | ANTILYMPHOCYTE ACTION | 13 | 71% | 1% | 10 |
| 4 | MEDIATED PHARMACODYNAMICS | 12 | 86% | 1% | 6 |
| 5 | PREDNISOLONE PHARMACODYNAMICS | 11 | 100% | 1% | 6 |
| 6 | IMMUNOSUPPRESSANT PHARMACODYNAMICS | 9 | 83% | 1% | 5 |
| 7 | SUPPRESSIVE POTENCY | 8 | 100% | 1% | 5 |
| 8 | IMMUNOSUPPRESSIVE POTENCY | 6 | 58% | 1% | 7 |
| 9 | 6 BETA HYDROXYPREDNISOLONE | 6 | 100% | 1% | 4 |
| 10 | HEMISUCCINATE | 4 | 27% | 2% | 12 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids | 2005 | 231 | 289 | 33% |
| Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation | 2012 | 5 | 206 | 34% |
| KINETICS AND DYNAMICS OF PREDNISOLONE | 1987 | 36 | 85 | 81% |
| PROBLEMS WITH THE EQUIVALENCE CONCEPT IN THE THERAPEUTIC USE OF GLUCOCORTICOIDS - COMPARISON OF CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF PREDNISOLONE AND METHYLPREDNISOLONE | 1994 | 7 | 28 | 79% |
| What Do We Know About Steroids Metabolism and 'PK/PD Approach' in AKI and CKD Especially While on RRT - Current Status in 2014 | 2014 | 0 | 8 | 50% |
| Corticosteroid use in the treatment of neuromuscular disorders: Empirical and evidence-based data | 2004 | 21 | 82 | 18% |
| Review in pharmacokinetic models on corticosteroids | 2006 | 1 | 56 | 50% |
| Can We Personalize Treatment for Kidney Diseases? | 2009 | 8 | 48 | 10% |
| Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine | 2007 | 8 | 179 | 20% |
| Clinical pharmacokinetics of glucocorticoids | 1999 | 0 | 66 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOTOYAMAKITA MACHI HIGASHINADA KU | 2 | 67% | 0.3% | 2 |
| 2 | CLIN NEPHROL RHEUMATOL P MED INFECT CONT | 1 | 38% | 0.4% | 3 |
| 3 | PHARM 565 HOCHSTETTER HALL | 1 | 100% | 0.3% | 2 |
| 4 | ANATOMOPATHOL CYTOGENET | 1 | 50% | 0.1% | 1 |
| 5 | CIENCIAS VET UNCPBA | 1 | 50% | 0.1% | 1 |
| 6 | INFANTRISK | 1 | 50% | 0.1% | 1 |
| 7 | PHARM PHARMACEUT 565 HOCHSTETTER HALL | 1 | 50% | 0.1% | 1 |
| 8 | PHARM S926 | 1 | 50% | 0.1% | 1 |
| 9 | QUEENSLAND HTLH PATHOL SERV | 1 | 50% | 0.1% | 1 |
| 10 | RRA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000179709 | 6 BETA HYDROXYCORTISOL//PARTIAL COMPONENT REGRESSION//GLOBAL QUAL SERV ANALYT SCI |
| 2 | 0.0000144334 | ARIZONA RHEUMATOL//INTRAVENOUS PULSE METHYLPREDNISOLONE//KALIEMIA |
| 3 | 0.0000107469 | DEFLAZACORT//GLUCOCORTICOID INDUCED DIABETES//STEROID DIABETES |
| 4 | 0.0000085518 | STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL |
| 5 | 0.0000076752 | POSTNATAL AGES//ANTIARTHRITIC EFFECT//CELL BIOL VIA GD ROMAGNOSI 18A |
| 6 | 0.0000075553 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |
| 7 | 0.0000072539 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION |
| 8 | 0.0000065529 | CARDIOVASC METAB ENDOCRINE CLIN//CONSTITUTION TYPE//CRI 98002 |
| 9 | 0.0000057520 | GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION |
| 10 | 0.0000057077 | STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE |